GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surmodics Inc (NAS:SRDX) » Definitions » E10

SRDX (Surmodics) E10 : $-0.02 (As of Dec. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Surmodics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Surmodics's adjusted earnings per share data for the three months ended in Dec. 2024 was $-0.260. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.02 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Surmodics's average E10 Growth Rate was -110.50% per year. During the past 3 years, the average E10 Growth Rate was -59.20% per year. During the past 5 years, the average E10 Growth Rate was -27.70% per year. During the past 10 years, the average E10 Growth Rate was -14.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Surmodics was 15.80% per year. The lowest was -59.20% per year. And the median was -8.30% per year.

As of today (2025-03-14), Surmodics's current stock price is $28.30. Surmodics's E10 for the quarter that ended in Dec. 2024 was $-0.02. Surmodics's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Surmodics was 1000.75. The lowest was 30.91. And the median was 99.50.


Surmodics E10 Historical Data

The historical data trend for Surmodics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surmodics E10 Chart

Surmodics Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.41 0.59 0.37 0.23 0.04

Surmodics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.17 0.08 0.04 -0.02

Competitive Comparison of Surmodics's E10

For the Medical Devices subindustry, Surmodics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surmodics's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surmodics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Surmodics's Shiller PE Ratio falls into.



Surmodics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Surmodics's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.26/133.1571*133.1571
=-0.260

Current CPI (Dec. 2024) = 133.1571.

Surmodics Quarterly Data

per share eps CPI Adj_EPS
201503 0.230 99.621 0.307
201506 0.300 100.684 0.397
201509 0.220 100.392 0.292
201512 0.200 99.792 0.267
201603 0.060 100.470 0.080
201606 0.300 101.688 0.393
201609 0.200 101.861 0.261
201612 0.170 101.863 0.222
201703 0.040 102.862 0.052
201706 0.050 103.349 0.064
201709 0.030 104.136 0.038
201712 -0.120 104.011 -0.154
201803 0.110 105.290 0.139
201806 -0.200 106.317 -0.250
201809 -0.130 106.507 -0.163
201812 0.090 105.998 0.113
201903 0.090 107.251 0.112
201906 0.110 108.070 0.136
201909 0.260 108.329 0.320
201912 0.010 108.420 0.012
202003 0.110 108.902 0.135
202006 0.180 108.767 0.220
202009 -0.220 109.815 -0.267
202012 -0.020 109.897 -0.024
202103 0.580 111.754 0.691
202106 -0.240 114.631 -0.279
202109 -0.020 115.734 -0.023
202112 -0.200 117.630 -0.226
202203 -0.290 121.301 -0.318
202206 -0.410 125.017 -0.437
202209 -1.060 125.227 -1.127
202212 -0.560 125.222 -0.595
202303 -0.550 127.348 -0.575
202306 0.520 128.729 0.538
202309 0.470 129.860 0.482
202312 -0.060 129.419 -0.062
202403 0.020 131.776 0.020
202406 -0.530 132.554 -0.532
202409 -0.240 133.029 -0.240
202412 -0.260 133.157 -0.260

Add all the adjusted EPS together and divide 10 will get our e10.


Surmodics  (NAS:SRDX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Surmodics was 1000.75. The lowest was 30.91. And the median was 99.50.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Surmodics E10 Related Terms

Thank you for viewing the detailed overview of Surmodics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Surmodics Business Description

Traded in Other Exchanges
Address
9924 West 74th Street, Eden Prairie, MN, USA, 55344
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.
Executives
Timothy J. Arens officer: General Manager - IVD 9924 WEST 74TH STREET, EDEN PRAIRIE X1 55344
Jose H Bedoya director
David Dantzker other: See Explanation of Responses 80 CUTTERMILL ROAD STE 311, GREAT NECK NY 11021
Kalich Ronald B Sr director
Gary R Maharaj director, officer: President & CEO 9924 WEST 74TH STREET, EDEN PRAIRIE MN 55344
Joseph J. Stich officer: VP, Corp Dev & Strat Planning 9924 WEST 74TH STREET, EDEN PRAIRIE MN 55344
Charles W Olson officer: General Manager
John D. Manders officer: Corporate Controller 9924 WEST 74TH STREET, EDEN PRAIRIE MN 55344
Gordon S. Weber officer: Sr. VP of Legal, GC and Sec. 9924 WEST 74TH STREET, EDEN PRAIRIE MN 55344
Nusrath Sultana officer: VP, Clinical Affairs 9924 WEST 74TH STREET, EDEN PRAIRIE MN 55344
Lisa Wipperman Heine director 1244 76TH STREET WEST, INVER GROVE HEIGHTS MN 55077
Teri Woodwick Sides officer: Senior VP and CMO 9924 WEST 74TH STREET, EDEN PRAIRIE MN 55344
Gregg S Sutton officer: VP of Research and Development 6464 SYCAMORE COURT NORTH, MINNEAPOLIS MN 55369
Susan E Knight director 9154 BRECKENRIDGE LANE, EDEN PRAIRIE MN 55437
Bryan K Phillips officer: Dep. Gen. Counsel & Corp. Sec. 9924 WEST 74TH STREET, EDEN PRAIRIE MN 55344